Hostname: page-component-6766d58669-bkrcr Total loading time: 0 Render date: 2026-05-24T12:32:41.187Z Has data issue: false hasContentIssue false

Determinants of re-operation for bleeding in head and neck cancer surgery

Published online by Cambridge University Press:  08 March 2018

E Haapio*
Affiliation:
Department of Otorhinolaryngology, Turku University Hospital and University of Turku, Finland
I Kinnunen
Affiliation:
Department of Otorhinolaryngology, Turku University Hospital and University of Turku, Finland
J K E Airaksinen
Affiliation:
Heart Center, Turku University Hospital and University of Turku, Finland
H Irjala
Affiliation:
Department of Otorhinolaryngology, Turku University Hospital and University of Turku, Finland
T Kiviniemi
Affiliation:
Heart Center, Turku University Hospital and University of Turku, Finland
*
Address for correspondence: Dr Eeva Haapio, Department of Otorhinolaryngology, Turku University Hospital, Kiinamyllynkatu 4-8, FIN-20521, Turku, Finland Fax: +358 2 3132030 E-mail: eeva.haapio@tyks.fi

Abstract

Objective:

Post-operative bleeding in the head and neck area is potentially fatal. This ‘real world’ study sought to assess factors that increase the risk of re-operation for post-operative bleeding in head and neck cancer surgery.

Methods:

A total of 456 patients underwent surgery for head and neck cancer (591 operations). The primary endpoint was re-operation for bleeding.

Results:

The rate of re-operation for bleeding was 5 per cent of all operations. Re-operation for bleeding was an independent risk factor for 30-day mortality (odds ratio = 5.27, p = 0.014). Risk factors for re-operation because of bleeding included excessive (more than 4000 ml) fluid administration (over 24 hours) (p < 0.001), heavy alcohol consumption (p = 0.014), pre-operative oncological treatment (p = 0.017), advanced disease stage (p = 0.020) and higher tumour (T) classification (p = 0.034). Operations with more excessive bleeding (700 ml or more) were associated with an increased risk (p = 0.001) of re-operation for post-operative bleeding. Moreover, the risk of re-operation was significantly higher in patients undergoing microvascular surgery compared to those who had no oncological treatment pre-operatively (18 vs 6 per cent, p = 0.001).

Conclusion:

The 30-day mortality risk increased over 5-fold in patients undergoing re-operation for bleeding.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable